Researchers have developed a so-called human challenge model for dengue vaccine, and used it to test a vaccine that was shown to evoke an immune response to all four strains of dengue virus, and protect against subsequent infection with serotype 2, which has been the most challenging serotype from a vaccine development standpoint.